325 related articles for article (PubMed ID: 10087042)
41. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.
Shinoda K; Hruby VJ; Porreca F
Neurosci Lett; 2007 Jan; 411(2):143-6. PubMed ID: 17110034
[TBL] [Abstract][Full Text] [Related]
42. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
43. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
[TBL] [Abstract][Full Text] [Related]
44. Peripheral antinociception induced by δ-opioid receptors activation, but not μ- or κ-, is mediated by Ca²⁺-activated Cl⁻ channels.
Pacheco Dda F; Pacheco CM; Duarte ID
Eur J Pharmacol; 2012 Jan; 674(2-3):255-9. PubMed ID: 22134006
[TBL] [Abstract][Full Text] [Related]
45. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
46. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
Kumar K; Kumar S; Kurupati RK; Seth MK; Mohan A; Hussain ME; Pasha S
Eur J Pharmacol; 2011 Jan; 650(1):28-33. PubMed ID: 20887721
[TBL] [Abstract][Full Text] [Related]
47. Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profiles.
Le Bourdonnec B; Barker WM; Belanger S; Wiant DD; Conway-James NC; Cassel JA; O'Neill TJ; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2008 Mar; 18(6):2006-12. PubMed ID: 18313920
[TBL] [Abstract][Full Text] [Related]
48. Opioid receptor affinity and analgesic activity of O- and C-glycosylated opioid peptides.
Negri L; Melchiorri P; Rocchi R; Scolaro B
Acta Physiol Hung; 1996; 84(4):441-3. PubMed ID: 9328626
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
[TBL] [Abstract][Full Text] [Related]
50. Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors.
McLaughlin JP; Nowak D; Sebastian A; Schultz AG; Archer S; Bidlack JM
Eur J Pharmacol; 1995 Dec; 294(1):201-6. PubMed ID: 8788432
[TBL] [Abstract][Full Text] [Related]
51. Involvement of peripheral opioid receptors in electroacupuncture analgesia for carrageenan-induced hyperalgesia.
Taguchi R; Taguchi T; Kitakoji H
Brain Res; 2010 Oct; 1355():97-103. PubMed ID: 20707990
[TBL] [Abstract][Full Text] [Related]
52. Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range.
Codd EE; Ma J; Zhang SP; Stone DJ; Colburn RW; Brandt MR; Chevalier KM; Zhu Y; Peng S; Cai C; Acton PD; Flores CM
Pharmacol Biochem Behav; 2010 Aug; 96(2):130-5. PubMed ID: 20438745
[TBL] [Abstract][Full Text] [Related]
53. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.
Bruce DJ; Peterson CD; Kitto KF; Akgün E; Lazzaroni S; Portoghese PS; Fairbanks CA; Wilcox GL
Anesthesiology; 2019 Sep; 131(3):649-663. PubMed ID: 31343460
[TBL] [Abstract][Full Text] [Related]
54. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
55. N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors.
Onali P; Olianas MC
Neuropsychopharmacology; 2007 Apr; 32(4):773-85. PubMed ID: 16841075
[TBL] [Abstract][Full Text] [Related]
56. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.
Fraser GL; Gaudreau GA; Clarke PB; Ménard DP; Perkins MN
Br J Pharmacol; 2000 Apr; 129(8):1668-72. PubMed ID: 10780972
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
[TBL] [Abstract][Full Text] [Related]
58. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
59. Urinary bladder relaxation through activation of opioid μ-receptors induced by loperamide is increased in diabetic rats.
Lee LM; Lin CS; Chung HH; Lin KC; Cheng JT
Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):323-8. PubMed ID: 22187294
[TBL] [Abstract][Full Text] [Related]
60. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
